Rock Point Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Sell
6,700
-150
-2% -$7.11K 0.07% 101
2025
Q4
$349K Hold
6,850
0.09% 88
2025
Q3
$380K Hold
6,850
0.1% 80
2025
Q2
$473K Sell
6,850
-150
-2% -$10.2K 0.13% 73
2025
Q1
$486K Hold
7,000
0.15% 74
2024
Q4
$602K Sell
7,000
-100
-1% -$10.8K 0.18% 57
2024
Q3
$845K Hold
7,100
0.23% 54
2024
Q2
$1.01M Hold
7,100
0.3% 49
2024
Q1
$912K Sell
7,100
-300
-4% -$35.7K 0.27% 53
2023
Q4
$766K Hold
7,400
0.23% 52
2023
Q3
$673K Hold
7,400
0.23% 56
2023
Q2
$599K Hold
7,400
0.2% 60
2023
Q1
$589K Sell
7,400
-200
-3% -$14.2K 0.2% 61
2022
Q4
$514K Hold
7,600
0.18% 67
2022
Q3
$379K Hold
7,600
0.14% 66
2022
Q2
$423K Hold
7,600
0.14% 67
2022
Q1
$422K Hold
7,600
0.13% 63
2021
Q4
$426K Hold
7,600
0.12% 67
2021
Q3
$365K Hold
7,600
0.11% 67
2021
Q2
$318K Hold
7,600
0.09% 72
2021
Q1
$256K Sell
7,600
-400
-5% -$14.2K 0.08% 81
2020
Q4
$279K Hold
8,000
0.1% 72
2020
Q3
$278K Hold
8,000
0.12% 65
2020
Q2
$262K Hold
8,000
0.12% 67
2020
Q1
$241K Sell
8,000
-1,000
-11% -$29.8K 0.14% 61
2019
Q4
$260K Buy
+9,000
New +$249K 0.11% 70

Other funds holding NVO

Rock Point Advisors's NVO Position: Q1 2026 in Review

Rock Point Advisors reduced its Novo Nordisk (NVO) stake by 2.2% in Q1 2026, selling an estimated $7.11K and leaving 6,700 shares worth $246K. The position accounts for 0.07% of the portfolio, ranked #101.

Rock Point Advisors first reported a position in NVO in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.01M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Rock Point Advisors held 6,700 shares of Novo Nordisk worth $246K as of Q1 2026.
  • Rock Point Advisors sold 150 Novo Nordisk shares in Q1 2026, an estimated $7.11K.
  • Novo Nordisk made up 0.07% of Rock Point Advisors's portfolio in Q1 2026, its #101 holding.
  • Rock Point Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 26 quarters since.
  • Rock Point Advisors's Novo Nordisk position peaked at $1.01M in Q2 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Rock Point Advisors's 13F filing for Q1 2026, filed 14 May 2026.